Research
Energy balance
The 30-day and 90-day readmission rates were similar between semaglutide-treated patients and controls.
This indicates that semaglutide does not increase the likelihood of readmission after surgery.
StrongRefutesmedium confidence
Similarly, both 30-day (OR 0.83, 95% CI 0.49-1.42, P =0.589) and 90-day readmission rate (OR 0.89, 95% CI 0.56-1.42, P =0.724) were similar between both cohorts.
Why this rating
Based on a retrospective cohort study design with a matched analysis.
Source
No Difference in Short-term Surgical Outcomes From Semaglutide Treatment for Type 2 Diabetes Mellitus After Cervical Decompression and Fusion
Tao Xu et al. · Spine · 2024
DOI 10.1097/brs.0000000000005099
cohort · n=596Cited 15×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Semaglutide treatment is not associated with higher rates of short-term adverse events after cervical spine decompression and fusion in patients with Type 2 Diabetes Mellitus.Strong
- There are no statistically significant differences in the composite measure of postoperative surgical complications between semaglutide-treated patients and controls.Strong
Related findings · Energy balance
- Achieving a total body weight loss of 10-15% (or >10-15 kg) through Total Diet Replacement (TDR) induces remission of Type 2 Diabetes in individuals with short-duration disease.Strong
- Bariatric surgery is superior to medical management alone for inducing significant long-term weight loss, remission of type 2 diabetes, and reduction in mortality for patients with BMI ≥ 40 or ≥ 35 with comorbidities.Strong
- Achieving type 2 diabetes remission requires significant weight loss (≥15 kg) via major caloric restriction, independent of macronutrient composition.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →